Noninvasive prenatal fetal aneuploidy panel - Plasma cell-free DNA   73967-2

LOINC Code


LOINC code73967-2
nameNoninvasive prenatal fetal aneuploidy panel - Plasma cell-free DNA
descriptionNoninvasive prenatal testing for risk of fetal aneuploidy (e.g. trisomy 21, XXY, etc.) is performed using maternal plasma (or serum) which contains circulating cell free (ccf) DNA from the fetus. The probability and result interpretation (high risk/low risk) of aneuploidy are based on dosage ccf DNA from the mother and fetus as well as the mother's current age and gestational age. The ccf DNA includes both fetal and maternal DNA. This code is based, but not limited in use to, the submitter's test, Harmony Prenatal Test, which is a non-invasive prenatal test intended to aid in the risk determination of trisomy 13, 18 and 21 as well as fetal sex chromosome aneuploidy in women with singleton pregnancies of at least 10 weeks gestational age.
statusACTIVE

Fully-Specified Name

componentNoninvasive prenatal fetal aneuploidy panel
property-
timePt  =  Point in time:  To identify measures at a point in time. This is a synonym for “spot” or “random” as applied to urine measurements.
systemPlas.cfDNA
scale-
method

Additional Names

short nameNIP fet aneu Pnl Plas.cfDNA

Basic Attributes

classPANEL.MOLPATH
type1  Laboratory
order vs. observationOrder

Panel Components

73969-8Fetal Trisomy 13 risk [Likelihood] based on Plasma cell-free DNA by Dosage of chromosome-specific cfDNA
73824-5Fetal Trisomy 13 risk [Interpretation] based on Plasma cell-free DNA by Dosage of chromosome-specific cfDNA Qualitative
73968-0Fetal Trisomy 18 risk [Likelihood] based on Plasma cell-free DNA by Dosage of chromosome-specific cfDNA
73825-2Fetal Trisomy 18 risk [Interpretation] based on Plasma cell-free DNA by Dosage of chromosome-specific cfDNA Qualitative
73970-6Fetal Trisomy 21 risk [Likelihood] based on Plasma cell-free DNA by Dosage of chromosome-specific cfDNA
73966-4Fetal Trisomy 21 risk [Interpretation] based on Plasma cell-free DNA by Dosage of chromosome-specific cfDNA Qualitative
88572-3Fetal 22q11.2 deletion risk [Interpretation] based on Plasma cell-free DNA by Dosage of chromosome-specific cfDNA Qualitative
88571-5Fetal Monosomy X risk [Interpretation] based on Plasma cell-free DNA by Dosage of chromosome-specific cfDNA Qualitative
73821-1Fetal Chromosome X and Y aneuploidy risk [Likelihood] based on Plasma cell-free DNA by Dosage of chromosome-specific cfDNA
73822-9Chromosome X and Y aneuploidy in Plasma cell-free DNA by Dosage of chromosome-specific cfDNA Nominal
75693-2Fetal sex in Plasma cell-free DNA by Dosage of chromosome specific cell free (cf) DNA

Associated Observations

LOINC codes that represent optional associated observation(s) for a clinical observation or laboratory test. A LOINC term may represent a single associated observation or panel containing several associated observations.

History/Usage

first released
last updated2.73
last change typeMIN  - change to field other than name
change reasonRelease 2.70: COMPONENT: Removed "test" from Component name for consistency across similar terms.; Previous Releases: The system of 'Ser/Plas.maternal^fetus' was changed to 'Plas.cfDNA' (cfDNA from plasma, which includes both maternal and fetal DNA) to more precisely identify what is being measured.

Related Names

Molecular pathology
MOLPATH
NIP fet aneu Pnl
NIPS
Non-invasive prenatal screening
Noninvasive prenatal testing
NPT
Pan
Panel.molpath
Panl
Pl
Plasma
Plsm
Pnl
Point in time
Random

Copyright © 2024 Regenstrief Institute, Inc. All Rights Reserved. To the extent included herein, the LOINC table and LOINC codes are copyright © 1995-2024, Regenstrief Institute, Inc. and the Logical Observation Identifiers Names and Codes (LOINC) Committee. See https://loinc.org/license for the full LOINC copyright and license.

demo
request yours today
subscribe
start today
newsletter
free subscription

Thank you for choosing Find-A-Code, please Sign In to remove ads.